# COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

Study · id `cardio:ct-nct02404376` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02404376](<https://clinicaltrials.gov/study/NCT02404376>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02404376

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 378 participants.

## Technical summary

Registry record NCT02404376. Randomized; double masking; primary purpose treatment. Start 2016-03 (actual); primary completion 2019-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 378 participants (enrolled count; ClinicalTrials.gov record NCT02404376, source copy `cardio:ctgov-nct02404376-2020-11-03`, retrieved 2026-10-26)
- Started: 2016-03 (actual) (ClinicalTrials.gov record NCT02404376, source copy `cardio:ctgov-nct02404376-2020-11-03`, retrieved 2026-10-26)
- Primary completion: 2019-08 (actual) (ClinicalTrials.gov record NCT02404376, source copy `cardio:ctgov-nct02404376-2020-11-03`, retrieved 2026-10-26)
- Completion: 2020-06 (actual) (ClinicalTrials.gov record NCT02404376, source copy `cardio:ctgov-nct02404376-2020-11-03`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT02404376, source copy `cardio:ctgov-nct02404376-2020-11-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02404376-2020-11-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
- Acronym: COMBAT-MI
- Condition: ST Elevation Acute Myocardial Infarction
- Intervention (Drug): Exenatide
- Intervention (Other): Remote Ischemic Conditioning (RIC)
- Intervention (Drug): Placebo
- Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Hospital Universitari Vall d'Hebron Research Institute (`cardio:org-hospital-universitari-vall-d-hebron-research-institute`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Spontaneous reperfusion enhances succinate concentration in peripheral blood from stemi patients but its levels does not correlate with myocardial infarct size or area at risk (`cardio:pubmed-37106099`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5b4359f385e0612979295b85d7af429befcf6a0f17a5f9eae41f12d4bef4a7a7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
